Sunday, February 5, 2023
  • Home
  • Featured
  • Parenting
  • Pregnancy
  • Birth
  • Lifestyle
  • Shop
Baby Care News
  • Home
  • Featured
  • Parenting
  • Pregnancy
  • Birth
  • Lifestyle
  • Shop
No Result
View All Result
  • Home
  • Featured
  • Parenting
  • Pregnancy
  • Birth
  • Lifestyle
  • Shop
No Result
View All Result
Baby Care News
No Result
View All Result
Home Pregnancy

Antidepressant Use During Pregnancy Shows No Increased Risk of Neurodevelopmental Disorders in Children

by Baby Care News
October 20, 2022
in Pregnancy
Reading Time: 2 mins read
A A
0
1b052579dcff87f566a2386e53ac28cd38f8d8d8
Share on FacebookShare on Twitter


Using health care utilization data and controlling for confounding by indication, environment, and genetics, findings from a recently published study of nearly 150,000 antidepressant-exposed pregnancies showed that use of these medications during pregnancy itself does not increase the risk of neurodevelopmental disorders (NDDs) in children. However, this may indicate the need to screen and intervene early, as there are strong associations.1

The defined pregnancy groups were nested in both the Medicaid Analytic eXtract(MAX), which contains health care utilization data for Medicaid beneficiaries nationwide, 2000-2014, and the MarketScan Commercial Claims Database which contains private health insurance claims data, 2003-2015. The total number of pregnancies exposed to antidepressants at late pregnancy was 93,069, 52,633 and 1,833,927 respectively.

Led by Elizabeth A. Suarez, PhD, MPH, pharmacoepidemiologist, Rutgers Institute for Health, Health Care Policy and Aging Research, the study followed children from birth until outcome diagnosis, disenrollment, death, or end of study (maximum, 14 years). Neurodevelopmental outcomes included diagnosis of autism spectrum disorder (ASD), attention defect disorder (ADHD), certain learning disorders, developmental speech/language disorders, developmental coordination disorder or intellectual disability and any NDD (presence any of the 7 specific disorders).

Children of antidepressant-exposed parents had a higher incidence of NDDs. At 12 years old, 46.8% (95%CI, 45.6-48.1), and 24.9% (95%CI, 23.0-26.9) of the MAX cohort had experienced any type of NDD. This was compared to 31.4% (95%CI, 31.1-31.6) or 15.1% (95%CI, 14.7-15.4) for unexposed children in the same cohorts. ADHD was the most common individual outcome in NDD. There were 33.3% (95%CI), 32.2-34.5 and 20.3% (95%CI), 20.0-20.9) incidence rates for those who took antidepressants in MAX or MarketScan. These rates were lower than the 17.6% (95%CI), 15.8-19.5) and 9.6% (95%CI), 9.3-10.0 for unexposed individuals.

The incidence of ASD was similarly higher in antidepressant-exposed children and publicly insured children. At 12 years, 4.1% (95% CI, 3.5-4.7) and 2.1% (95% CI, 2.0-2.1) of antidepressant-exposed children developed ASD vs 2.9% (95% CI, 2.4-3.6) and 1.6% (95% CI, 1.4-1.7) of those unexposed to treatment in the same cohorts, respectively. Crude HRs of all NDD outcomes indicated an increase in risk. HRs ranged between 1.32 and 2.02 for ADHD in children exposed to antidepressants during pregnancy compared to those who were not. After adjusting to measure covariates and proxy for unmeasured variables, HRs for all NDDS were significantly reduced, ranging between 1.01 for certain learning disorders and 1.20 for ADHD.

The sibling design was not subject to sensitivity analysis. These analyses did not show that there were any carryover effects from the first pregnancy’s exposure to the outcome of the second. The study included several antidepressants, but no one therapy was found to significantly increase the risk of NDD. The adjusted HRs for escitalopram across all outcomes was comparable to those for other drugs and classes. Results were also similar for all ages regardless of whether they were exposed in the late or early stages of pregnancy when NDD risk was calculated based on antidepressant timing.

REFERENCE
1.Suarez EA, Bateman BT, Hernandez-Diaz S, et al. Association of antidepressant use in pregnancy with the risk of neurodevelopmental disorder in children. JAMA Intern Med. Published online October 3, 2022. doi:10.1001/jamainternmed.2022.4268



Source link

Tags: antidepressantChildrendisordersIncreasedneurodevelopmentalpregnancyRiskShows
Previous Post

Quebec MNAs announce birth of son

Next Post

‘You Are Right to Cry’

Related Posts

VKFWWWXJXZCCLIIYNOYEWKNAZQ
Pregnancy

Boston Marathon changes pregnancy policy after Fiona English’s open letter

February 2, 2023
20230201 preg mig
Pregnancy

Migraine history may be marker of pregnancy risks – Harvard Gazette

February 1, 2023
Spears DryLand2
Pregnancy

‘Dry Land,’ debuting Feb. 6 at the Hippodrome, tackles young female friendship and unwanted pregnancy

January 31, 2023
HD2659319021image
Pregnancy

Smoking in Pregnancy Greatly Raises Odds for SIDS in Newborns

January 30, 2023
Tia Clair Toomey workout
Pregnancy

6x Fittest Woman on Earth Shows Off Her Strength as She Trains During Pregnancy

January 29, 2023
newspress collage 21196815 1674927356612
Pregnancy

Lucy Fallon breaks silence after birth rumours to give major pregnancy update

January 28, 2023
Next Post
Chip and Joanna Gaines 1

'You Are Right to Cry'

03398f1be735a5ef0350a349e5d75640

IVF Babies Born to Black Mothers Face Higher Infant Mortality Rates

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

  • Disclaimer
  • Privacy Policy
  • DMCA
  • Cookie Privacy Policy
  • Terms and Conditions
  • Contact us
BABY CARE NEWS

Copyright © 2023 - Baby Care News.
Baby Care News is not responsible for the content of external sites.

No Result
View All Result
  • Home
  • Featured
  • Parenting
  • Pregnancy
  • Birth
  • Lifestyle
  • Shop

Copyright © 2023 - Baby Care News.
Baby Care News is not responsible for the content of external sites.